From Surgical Devices to Integrated Health Outcomes

Monetizing Clinical & Economic Value

The Trend

In Value-Based Healthcare, clinical performance is no longer enough. Hospital buyers now expect clear proof of economic impact—especially for technologies positioned at a premium price point.

• Consequences on Value Creation
  Without quantified financial evidence, clinically superior products face procurement pushback and prolonged VAC cycles. Manufacturers risk margin erosion and shrinking differentiation against lower-cost alternatives.
• Our Solution
  We deploy the Clinical ROI Optimizer—interactive, tablet-based tools that allow reps to model the real-world cost savings of your technology (e.g., avoided complications, reduced LOS).
  We also generate VAC-Ready Business Cases, producing automated evidence packs tailored to each hospital’s data.
  Through our partnership with VISCONTI, we upskill sales leaders to shift from technical, physician-led conversations to C-Suite economic dialogues grounded in efficiency, throughput, and workforce constraints.
• Financial Impact
  • Price Resilience: Protect premium positioning by demonstrating lower Total Cost of Care.
  • Faster Approvals: Cut VAC approval timelines from 14 months to ~7 months.
  • C-Suite Access: Achieve a 40% increase in engagement with hospital administrators and non-clinical decision-makers.

Designing Profitable Digital Service Models

The Trend
Medical devices are becoming fully connected platforms, generating continuous data and enabling predictive insights. Yet most MedTech firms still monetize only the hardware—leaving significant digital value uncaptured.

• Consequences on Value Creation
  When software features are bundled for free, firms erode margins, dilute R&D ROI, and miss the shift toward recurring revenue models. Hardware-only pricing also weakens differentiation and exposes products to procurement-driven price pressure.
• Our Solution
  We design Decoupled Tiered Pricing models that separate physical devices from premium digital capabilities (predictive analytics, EHR integrations, workflow automation).
  We architect Risk-Sharing Contracts, embedding clinical KPIs into CPQ logic to support outcome-linked billing.
  We implement Lifecycle & Renewal Engines that automate annual license management, driving predictable ARR and strengthening strategic customer lock-in.
• Financial Impact
  • EBITDA Growth: Capture $2M+ in previously unmonetized digital value.
  • Valuation Multiplier: Recurring-revenue–oriented firms typically achieve 2–3× higher valuation multiples.
  • Customer Lock-in: Deep integration into EHR and workflow systems creates substantial switching costs for competitors.

Winning the Shift to Ambulatory Surgery Centers (ASCs)

The Trend
The Site-of-Care shift is accelerating: procedures are rapidly moving from hospital ORs to Ambulatory Surgery Centers. ASCs operate with tighter margins, faster procurement cycles, and far higher volume expectations—fundamentally changing how MedTech is purchased.

• Consequences on Value Creation
  Traditional hospital-focused sales models collapse under ASC volume. High administrative load, slow quoting, and manual inventory processes lead to missed orders, escalating SG&A, and declining competitiveness against more agile rivals.
• Our Solution
  We implement High-Volume Lead-to-Cash Workflows so reps can manage 5× more accounts with dramatically lower admin time.
  We build Digital Self-Service Portals where ASC managers track orders, manage consignment stock, and access compliance files 24/7.
  We deploy AI-Driven Small-Account Automation, identifying fast-growing ASCs and prioritizing human intervention while automating routine replenishment for the rest.
• Financial Impact
  • Market Share Gain: Establish first-mover advantage in the fastest-growing segment of healthcare.
  • Sales Efficiency: Reduce ASC-segment SG&A by ~30% through digital automation.
  • Inventory Optimization: Cut trunk stock and consignment waste by ~20% with real-time site visibility.